ATRESM.C.D.M.ADR/1/EO-75 (F:YT2) — Stock Price
ATRESM.C.D.M.ADR/1/EO-75 (F:YT2) is currently trading at €4.90 EUR, down 1.21% today. Over the past 52 weeks, shares have ranged between €4.34 and €6.00. This page tracks ATRESM.C.D.M.ADR/1/EO-75's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ATRESM.C.D.M.ADR/1/EO-75 market cap and net worth.
ATRESM.C.D.M.ADR/1/EO-75 (YT2) Stock Price Chart — Daily History & Trading Volume
The chart below tracks ATRESM.C.D.M.ADR/1/EO-75's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
ATRESM.C.D.M.ADR/1/EO-75 Income Statement — Revenue, Profit & Earnings by Year
ATRESM.C.D.M.ADR/1/EO-75's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | €893.75 Million | €918.95 Million | €886.11 Million | €867.29 Million |
| Cost of Revenue | €423.87 Million | €419.76 Million | €424.03 Million | €412.42 Million |
| Gross Profit | €469.87 Million | €499.20 Million | €462.08 Million | €454.87 Million |
| Research & Development | — | — | — | — |
| SG&A | — | €52.87 Million | €50.79 Million | €48.52 Million |
| Total Operating Expenses | €823.61 Million | €758.68 Million | €729.73 Million | €712.28 Million |
| Operating Income | €70.14 Million | €160.27 Million | €156.37 Million | €155.00 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | €8.48 Million | €9.39 Million | €11.51 Million | €9.77 Million |
| Income Before Tax | €81.33 Million | €160.33 Million | €147.66 Million | €150.39 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | €62.11 Million | €120.28 Million | €171.16 Million | €112.91 Million |
ATRESM.C.D.M.ADR/1/EO-75 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes ATRESM.C.D.M.ADR/1/EO-75's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Assets | €1.48 Billion | €1.50 Billion | €1.46 Billion | €1.51 Billion |
| Total Current Assets | €806.84 Million | €826.97 Million | €761.98 Million | €825.23 Million |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | €12.58 Million | €10.03 Million | €18.51 Million | €89.24 Million |
| Net Receivables | €268.91 Million | €265.80 Million | €257.85 Million | €267.51 Million |
| Inventory | €208.55 Million | €3.80 Million | €8.14 Million | €10.86 Million |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | €190.62 Million | €162.17 Million | €162.34 Million | €158.92 Million |
| Total Liabilities | €745.49 Million | €673.38 Million | €703.74 Million | €823.84 Million |
| Total Current Liabilities | €407.47 Million | €557.32 Million | €436.42 Million | €528.60 Million |
| Long-term Debt | €198.69 Million | €28.53 Million | €160.48 Million | €182.69 Million |
| Net Debt | — | — | €473.00K | €118.94 Million |
| Total Stockholder Equity | €732.91 Million | €830.10 Million | €759.98 Million | €685.13 Million |
| Retained Earnings | €62.11 Million | €518.18 Million | €444.59 Million | €351.58 Million |
ATRESM.C.D.M.ADR/1/EO-75 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how ATRESM.C.D.M.ADR/1/EO-75 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | €81.55 Million | €191.16 Million | €167.04 Million | €125.39 Million |
| Capital Expenditures | €15.98 Million | €14.93 Million | €29.79 Million | €19.99 Million |
| Free Cash Flow | €65.57 Million | €176.23 Million | €137.26 Million | €105.40 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | €146.37 Million | €101.33 Million | €90.07 Million | €94.58 Million |
| Stock-Based Compensation | — | — | — | — |
| Depreciation | €18.99 Million | €18.54 Million | €16.75 Million | €17.79 Million |
| Change in Cash | €-52.05 Million | €102.08 Million | €29.60 Million | €-92.05 Million |
ATRESM.C.D.M.ADR/1/EO-75 Earnings History — EPS Actual vs. Analyst Estimates
Track ATRESM.C.D.M.ADR/1/EO-75's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 28, 2026 | — | — | — |
| Jul 22, 2025 | — | — | — |
| Apr 23, 2025 | — | — | — |
| Feb 26, 2025 | — | — | — |